Molina-Molina, MaríaCastellví, IvánValenzuela, ClaudiaRamirez, JoséRodríguez Portal, José AntonioFranquet, TomásNarváez, Javier2023-05-032023-05-032022-08-05http://hdl.handle.net/10668/19692Fibrotic interstitial lung disease (ILD) is a frequent and severe complication of connective tissue disease (CTD). In this narrative review, we update the most relevant differential characteristics of fibrotic ILD associated with CTD (CTD-ILD) and propose a diagnostic and therapeutic approach based on a review of the articles published between 2002 and 2022 through PubMed. The subset of ILD, mainly the radiological/histological pattern and the degree of fibrotic component, usually determines the prognosis and therapeutic strategy for these patients. Some patients with CTD-ILD can develop progressive pulmonary fibrosis (PPF) with severe deterioration of lung function, rapid progression to chronic respiratory failure, and high mortality. PPF has been described in many CTDs, mainly in systemic sclerosis and rheumatoid arthritis, and requires a multidisciplinary diagnostic and therapeutic approach to improve patient outcomes.enAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/Interstitial lung diseaseconnective tissue diseasediagnosismultidisciplinary consultationprogressive pulmonary fibrosistreatmentConnective Tissue DiseasesHumansLung Diseases, InterstitialPrognosisPulmonary FibrosisScleroderma, Systemicresearch article35912842open access10.1080/17476348.2022.21075081747-6356https://www.tandfonline.com/doi/pdf/10.1080/17476348.2022.2107508?needAccess=true